Prati
Zdravko Lackovic
Zdravko Lackovic
Profesor farmakologije, Sveučilište u Zagrebu Medicinski fakultet
Potvrđena adresa e-pošte na mef.hr
Naslov
Citirano
Citirano
Godina
Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A
I Matak, L Bach-Rojecky, B Filipović, Z Lacković
Neuroscience 186, 201-207, 2011
2282011
Botulinum toxin A, brain and pain
I Matak, Z Lacković
Progress in neurobiology 119, 39-59, 2014
1842014
Content of home pharmacies and self-medication practices in households of pharmacy and medical students in Zagreb, Croatia: findings in 2001 with a reference to 1977.
V Aljinović-Vučić, V Trkulja, Z Lacković
Croatian Medical Journal 46 (1), 2005
1802005
Central origin of the antinociceptive action of botulinum toxin type A
L Bach-Rojecky, Z Lacković
Pharmacology Biochemistry and Behavior 94 (2), 234-238, 2009
1692009
Botulinum toxin’s axonal transport from periphery to the spinal cord
I Matak, P Riederer, Z Lacković
Neurochemistry international 61 (2), 236-239, 2012
1592012
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection
L Bach-Rojecky, M Šalković-Petrišić, Z Lacković
European journal of pharmacology 633 (1-3), 10-14, 2010
1492010
Effect of long‐lasting diabetes mellitus on rat and human brain monoamines
Z Lacković, M Šlković, Z Kuci, M Relja
Journal of neurochemistry 54 (1), 143-147, 1990
1481990
Botulinum toxin type A in experimental neuropathic pain
L Bach-Rojecky, M Relja, Z Lacković
Journal of neural transmission 112, 215-219, 2005
1252005
Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy
B Filipović, I Matak, L Bach-Rojecky, Z Lacković
PLoS one 7 (1), e29803, 2012
1132012
Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain.
L Bach-Rojecky, Z Lacković
Croatian medical journal 46 (2), 2005
1092005
Spinal cord serotonin: a biochemical and immunohistochemical study following transection
M Hadjiconstantinou, P Panula, Z Lackovic, NH Neff
Brain research 322 (2), 245-254, 1984
991984
Streptozotocin and alloxan produce alterations in rat brain monoamines independently of pancreatic beta cells destruction
Z Lacković, M Šalković
Life Sciences 46 (1), 49-54, 1990
811990
Botulinum toxin type A in dental medicine
VRM Muñoz Lora, AA Del Bel Cury, B Jabbari, Z Lacković
Journal of dental research 98 (13), 1450-1457, 2019
802019
Simultaneous determination of femtomole quantities of 5-hydroxytryptophan, serotonin and 5-hydroxyindoleacetic acid in brain using HPLC with electrochemical detection
Z Lacković, M Parenti, NH Neff
European Journal of Pharmacology 69 (3), 347-352, 1981
781981
Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches
Z Lacković, B Filipović, I Matak, Z Helyes
British journal of pharmacology 173 (2), 279-291, 2016
772016
Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons
I Matak, O Rossetto, Z Lacković
PAIN® 155 (8), 1516-1526, 2014
772014
Involvement of μ-opioid receptors in antinociceptive action of botulinum toxin type A
V Drinovac, L Bach-Rojecky, I Matak, Z Lacković
Neuropharmacology 70, 331-337, 2013
762013
Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice
I Matak, V Tékus, Z Lacković, Z Helyes
Neuroscience 358, 137-145, 2017
702017
Reduced brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus
I Tahirovic, E Sofic, A Sapcanin, I Gavrankapetanovic, L Bach-Rojecky, ...
Neurochemical research 32, 1709-1717, 2007
672007
Use of psychoactive substances among Zagreb University medical students: follow-up study.
V Trkulja, Z Zivcec, M Cuk, Z Lacković
Croatian medical journal 44 (1), 50-58, 2003
672003
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20